Characterization of COVID-19 Patients in an Intensive Care Unit

Alberto Dariel Ramirez Gonzalez; Mabel Montero Castrillon; Lazaro Vazquez Vazquez

doi:doi:10.11648/j.ijcems.20210705.13

| Peer-Reviewed

Characterization of COVID-19 Patients in an Intensive Care Unit

Alberto Dariel Ramirez Gonzalez, Mabel Montero Castrillon, Lazaro Vazquez Vazquez

Published in International Journal of Clinical and Experimental Medical Sciences (Volume 7, Issue 5)

Received: 21 September 2021 Accepted: 8 October 2021 Published: 15 October 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

At the end of 2019 a new coronavirus caused an epidemic of acute respiratory disease in Wuhan, China. The World Health Organization called this condition "coronavirus disease 2019" and declared it pandemic on 11 March 2020. On that same date the first three COVID-19 cases were diagnosed in Cuba. The Acute Physiology and Chronic Health Evaluation II (APACHE II) is the disease severity scoring system most commonly used in ICUs. An observational descriptive prospective cohort study was carried out with the objective of describing the behavior of 20 SARS-CoV-2 positive cases in an intensive care unit. This was realized from March to July 2020 at the Intensive Care Unit of Dr Salvador Allende Clinical Surgical Hospital in Havana, Cuba. The study population was all the patients admitted for positive SARS-CoV-2 (n=20). Mean age was 64.35±15.21 years. Male sex prevailed. Mean hospital stay was 10.05±5.5 days. Mean APACHE II was 16.6±8.9. The prevailing symptoms were fever (55%), coughing (25%) and dyspnea (20%). Mortality of COVID-19 patients was associated to age, a longer stay in the intensive care unit, high APACHE II scores, reduced erythrosedimentation values and lymphocyte count. Hypertension was the most common pathological antecedent.

Published in	International Journal of Clinical and Experimental Medical Sciences (Volume 7, Issue 5)
DOI	10.11648/j.ijcems.20210705.13
Page(s)	143-151
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Intensive Care Unit, Severe Acute Respiratory Syndrome, Apache, Mechanical Ventilation, COVID-19

References

[1]	Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for C, (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Online magazine]. 2019 [Access: 14/07/2020]; 382: 1708-20. Available in: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032.
[2]	Gobierno de España. Actualización 46 COVID-19. Ministerio de Sanidad, Consumo y Bienestar Social; 2020. [Government of Spain. Update 46 COVID-19. Ministry of Health, Consumption and Social Welfare; 2020] [Internet] [Access: 14/07/2020]. Available in: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCovChina/do cumentos/Actualizacion_46_COVID-19.pdf.
[3]	OMS. Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. OMS; 2020 [WHO. Opening speech of the director general of the WHO at the press conference on COVID-19 held on March 11, 2020. WHO; 2020] [Internet] [Access: 14/07/2020]. Available in: https://www.who.int/es/dg/speeches/detail/who-director- general-s-opening-remarks-at-the-media-briefing-on-COVID-19 11-march-2020.
[4]	MINSAP. Protocolo de actuación nacional para la COVID-19. MINSAP; 2020 [Ministry of Public Health. National care protocol for COVID-19. Ministry of Public Health] [Internet] [Access: 14/07/2020]. Available in: https://files.sld.cu/editorhome/files/2020/05/MINSAP_Protocolo-de-Actuaci%25C3%25B3n-Nacional-para-la-COVID-19_versi%25C3%25B3.
[5]	MINSAP. Parte de cierre del día 13 de julio a las 12 de la noche. Sitio Oficial del gobierno del MINSAP de Cuba; 2020 [Ministry of Public Health. Closing part of July 13 at 12 at night. Official site of the Government of the Ministry of Public Health of Cuba] [Internet] [Access: 14/07/2020]. Available in: https://salud.msp.gob.cu/parte-de-cierre-del-dia-13-de-julio-a-las-12-de-la-noche/.
[6]	Chih Cheng L, Tzu Ping S, Wen Chien K, Hung Jen T, Po Ren H. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International Journal of Antimicrobial Agents [Internet]. 2020 [Access: 06/04/2020]; 55:[aprox. 1 p.]. Available in: http://doi.org/10.1016/j.ijantimicag.2020.105924.
[7]	Chisakuta AM, Alexander JP. Audit in intensive care. The APACHE II classification of severity of disease. Ulster Med J [Internet] 1990 [Access: 29/05/2020]; 59: 161-7. Available in: https://www.ncbi.nlm.nih.gov/m/pubmed/2278113.
[8]	Knaus WA, Drapper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985 [Access: 29/05/2020]; 3: 818-29. Available in: https://www.ncbi.nlm.nih.gov/m/pubmed/3928249.
[9]	Salluh JI, Soares M. ICU severity of illness scores: APACHE, SAPS and MPM. Curr Opin Crit Care. 2014 [Access: 29/05/2020]; 20 (5): 557-65. Available in: https://www.ncbi.nlm.nih.gov/m/pubmed/25137401.
[10]	De Ulibarri Pérez JI, González-Madrño Giménez A, González Pérez P, Fernández G, Rodríguez Salvanéz F, Mancha Álvarez-Estrada A, et al. Nuevo procedimiento para la detección precoz y control de la desnutrición hospitalaria. Nutrición Hospitalaria (España). 2002 [New procedure for the early detection and control of hospital nutrition. Hospital Nutrition (Spain). 2002] [Internet] [Access: 14/07/2020]; 17: 179-88. Available in: http://www.nutricionhospitalaria.com/pdf/3323.pdf.
[11]	Hernández OM, Hernández JA, Núrquez MA, Padrón MA. El estado nutricional al ingreso en una unidad de cuidados críticos como factor pronóstico de la evolución de la sepsis. Rev Cubana Aliment Nutr. 2018 [Nutritional status on admission to a critical care unit as a prognostic factor for the evolution of sepsis. Cuban magazine of food and nutrition. 2018] [Internet] [Access: 14/07/2020]; 28 (2): 314-27. Available in: http://www.revalnutricion.sld.cu/index.php/rcan/article/view/604.
[12]	ARDS Defnition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin defnition. JAMA 2012 [Access: 14/07/2020]; 307: 2526-33. Available in: https://pubmed.ncbi.nlm.nih.gov/22797452/.
[13]	CECMED. Centro de Inmunología Molecular. Itolizumab. (Anti CD6). Cuba abril del 2020 [Center for Molecular Immunology. Itolizumab (Anti CD6)] [Internet] [Access: 14/07/2020]. Available in: https://www.cecmed.cu/registro/rcp/heberonr- alfa-r-3-m-interferon-alfa-2b-humano-recombinante.
[14]	CECMED. Centro de Ingeniería Genética y Biotecnología. Heberferon Alfa R 10 M. (Interferon alfa 2B humano recombinante). Cuba 2020 [Center for Genetic engineering and biotechnoogy. Heberferon Alfa R 10 M. (Recombinant human interferón alfa 2B). Cuba, 2020] [Internet] [Access: 14/07/2020]. Available in: https://www.cecmed.cu/COVID-19/aprobaciones/itolizumab-anti-cd6-0.
[15]	CECMED. Centro de Ingeniería Genética y Biotecnología. Jusvinza (CIGB 258). Cuba. Junio del 2020 [Center for Genetic engineering and biotechnoogy. Jusvinza (CIGB 258)] [Internet] [Access: 14/07/2020]. Available in: https://www.cecmed.cu/COVID- 19/aprobaciones/jusvinza-cigb-258-1.
[16]	Hospital General de Massachusetts. Estratificación de riesgo COVID. [Access: 14/07/2020]. Available in: https://www.massgeneral.org/asset/MGH/pdf/news/coronavirus/estratificacion-de-riesgo- COVID.pdf.
[17]	Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet [revista en Internet]. 2020 [Access: 14/07/2020]; 395 (10229): 1054-62. Available in: https://www.thelancetcom/lancet/article/s0140-6736(20)30566-3.
[18]	Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020 [Access: 14/07/2020]. Available in: https://jamanetwork.com/journals/jama/fullarticle/2761044.
[19]	Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 [Internet] [Access: 14/07/2020]. Available in: https://jamanetwork.com/journals/jama/fullarticle/2762130.
[20]	Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristic of COVID-19 in New York City. N Engl J Med. 2020 [Internet] [Access: 14/07/2020]. Avaliable in: https://www.nejm.org/doi/full/10.1056/NEJMc2010419.
[21]	Carboni BI, Huespe I, Lockhart C, Massó A, González AJ, Hornos M, et al. COVID-19 en la terapia intensiva. análisis de la experiencia durante el primer mes de la pandemia. MEDICINA. 2020 [Internet] [Access: 14/07/2020]; 80 (4). Available in: https://www.medicinabuenosaires.com/indices-de-2020/volumen-80-año-2020-s-3- indice/COVID_terapia/.
[22]	Pan L, Mu M, Yang P. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020 [Internet] [Access: 14/07/2020]. Available in: https://pubmed.ncbi.nlm.nih.gov/32287140/.
[23]	American Academy of Otolaryngology–Head and Neck Surgery. AAO-HNS: anosmia, hyposmia, and dysgeusia symptoms of coronavirus disease. March 22, 2020. [Internet] [Access: 14/07/2020]. Available in: https://www.entnet.org/content/aao-hns-anosmia- hyposmia-and-dysgeusia-symptoms-coronavirus-disease.
[24]	Giacomelli A, Pezzati L, Conti F. Self-reported olfactory and taste disorders in SARS- CoV-2 patients: a cross sectional study. Clin Infect Dis. 2020 March 26. 2020 [Internet] [Access: 14/07/2020]. Available in: https://pubmed.ncbi.nlm.nih.gov/32215618/.
[25]	Bhatraju PK, Ghassemieh BJ, Nichols M. COVID-19 in critically Ill patients in the Seattle region - Case series. N Engl J Med 2020 [Internet] [Access: 14/07/2020]. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143164/.
[26]	Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020 [Internet] [Access: 14/07/2020]. Available in: https://pubmed.ncbi.nlm.nih.gov/32125452/.
[27]	Qingxian C, Fengjuan Ch, Fang L, Xiaohui L, Tao W, Qikai W, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. [Internet] [Access: 03/07/2020]. Available in: http://dx.doi.org/10.2139/ssrn.3556658.
[28]	Xu L, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver International. 2020 [Internet] [Access: 14/07/2020]. Available in: https://pubmed.ncbi.nlm.nih.gov/32170806/.
[29]	Fan Z, Chen L, Li Jun et al. Clinical Features of COVID-19-Related Liver Damage. medRxiv 2020. [Internet] [Access: 14/07/2020]. Available in: https://doi.org/10.1101/2020.02.26.20026971.
[30]	Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 [Internet] [Access: 14/07/2020]; 395 (10223): 507-513. Available in: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext.
[31]	Hospital General de Massachusetts. El hígado y el COVID-19 [Liver and COVI-19] [Internet] [Access: 14/07/2020]. Available in: https://www.massgeneral.org/asset/MGH/pdf/news/coronavirus/el-higado- y-COVID-19.pdf.
[32]	Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020 [Internet] [Access: 14/07/2020]. Available in: https://pubmed.ncbi.nlm.nih.gov/32119647/.
[33]	Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020 [Internet] [Access: 14/07/2020]; 505: 190-1. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094472/.
[34]	Herold T, Jurinovic V, Arnreich C. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. medRxiv April 2020 [Internet] 2019 [Access 14/07/2020]. Available in: https://www.medrxiv.org/content/10.1101/2020.04.01.20047381v2Acknowledgements.

Cite This Article

Plain Text BibTeX RIS

APA Style

Alberto Dariel Ramirez Gonzalez, Mabel Montero Castrillon, Lazaro Vazquez Vazquez. (2021). Characterization of COVID-19 Patients in an Intensive Care Unit. International Journal of Clinical and Experimental Medical Sciences, 7(5), 143-151. https://doi.org/10.11648/j.ijcems.20210705.13

Copy | Download

ACS Style

Alberto Dariel Ramirez Gonzalez; Mabel Montero Castrillon; Lazaro Vazquez Vazquez. Characterization of COVID-19 Patients in an Intensive Care Unit. Int. J. Clin. Exp. Med. Sci. 2021, 7(5), 143-151. doi: 10.11648/j.ijcems.20210705.13

Copy | Download

AMA Style

Alberto Dariel Ramirez Gonzalez, Mabel Montero Castrillon, Lazaro Vazquez Vazquez. Characterization of COVID-19 Patients in an Intensive Care Unit. Int J Clin Exp Med Sci. 2021;7(5):143-151. doi: 10.11648/j.ijcems.20210705.13

Copy | Download

@article{10.11648/j.ijcems.20210705.13,
  author = {Alberto Dariel Ramirez Gonzalez and Mabel Montero Castrillon and Lazaro Vazquez Vazquez},
  title = {Characterization of COVID-19 Patients in an Intensive Care Unit},
  journal = {International Journal of Clinical and Experimental Medical Sciences},
  volume = {7},
  number = {5},
  pages = {143-151},
  doi = {10.11648/j.ijcems.20210705.13},
  url = {https://doi.org/10.11648/j.ijcems.20210705.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20210705.13},
  abstract = {At the end of 2019 a new coronavirus caused an epidemic of acute respiratory disease in Wuhan, China. The World Health Organization called this condition "coronavirus disease 2019" and declared it pandemic on 11 March 2020. On that same date the first three COVID-19 cases were diagnosed in Cuba. The Acute Physiology and Chronic Health Evaluation II (APACHE II) is the disease severity scoring system most commonly used in ICUs. An observational descriptive prospective cohort study was carried out with the objective of describing the behavior of 20 SARS-CoV-2 positive cases in an intensive care unit. This was realized from March to July 2020 at the Intensive Care Unit of Dr Salvador Allende Clinical Surgical Hospital in Havana, Cuba. The study population was all the patients admitted for positive SARS-CoV-2 (n=20). Mean age was 64.35±15.21 years. Male sex prevailed. Mean hospital stay was 10.05±5.5 days. Mean APACHE II was 16.6±8.9. The prevailing symptoms were fever (55%), coughing (25%) and dyspnea (20%). Mortality of COVID-19 patients was associated to age, a longer stay in the intensive care unit, high APACHE II scores, reduced erythrosedimentation values and lymphocyte count. Hypertension was the most common pathological antecedent.},
 year = {2021}
}

Copy | Download

TY - JOUR
T1 - Characterization of COVID-19 Patients in an Intensive Care Unit
AU - Alberto Dariel Ramirez Gonzalez
AU - Mabel Montero Castrillon
AU - Lazaro Vazquez Vazquez
Y1 - 2021/10/15
PY - 2021
N1 - https://doi.org/10.11648/j.ijcems.20210705.13
DO - 10.11648/j.ijcems.20210705.13
T2 - International Journal of Clinical and Experimental Medical Sciences
JF - International Journal of Clinical and Experimental Medical Sciences
JO - International Journal of Clinical and Experimental Medical Sciences
SP - 143
EP - 151
PB - Science Publishing Group
SN - 2469-8032
UR - https://doi.org/10.11648/j.ijcems.20210705.13
AB - At the end of 2019 a new coronavirus caused an epidemic of acute respiratory disease in Wuhan, China. The World Health Organization called this condition "coronavirus disease 2019" and declared it pandemic on 11 March 2020. On that same date the first three COVID-19 cases were diagnosed in Cuba. The Acute Physiology and Chronic Health Evaluation II (APACHE II) is the disease severity scoring system most commonly used in ICUs. An observational descriptive prospective cohort study was carried out with the objective of describing the behavior of 20 SARS-CoV-2 positive cases in an intensive care unit. This was realized from March to July 2020 at the Intensive Care Unit of Dr Salvador Allende Clinical Surgical Hospital in Havana, Cuba. The study population was all the patients admitted for positive SARS-CoV-2 (n=20). Mean age was 64.35±15.21 years. Male sex prevailed. Mean hospital stay was 10.05±5.5 days. Mean APACHE II was 16.6±8.9. The prevailing symptoms were fever (55%), coughing (25%) and dyspnea (20%). Mortality of COVID-19 patients was associated to age, a longer stay in the intensive care unit, high APACHE II scores, reduced erythrosedimentation values and lymphocyte count. Hypertension was the most common pathological antecedent.
VL - 7
IS - 5
ER -

Copy | Download

Author Information

Alberto Dariel Ramirez Gonzalez

Clinical Science Department, Salvador Allende Faculty, Medical Science University of the Havana, Havana, Cuba
Mabel Montero Castrillon

Clinical Science Department, Salvador Allende Faculty, Medical Science University of the Havana, Havana, Cuba
Lazaro Vazquez Vazquez

Clinical Science Department, Salvador Allende Faculty, Medical Science University of the Havana, Havana, Cuba

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Alberto Dariel Ramirez Gonzalez, Mabel Montero Castrillon, Lazaro Vazquez Vazquez. (2021). Characterization of COVID-19 Patients in an Intensive Care Unit. International Journal of Clinical and Experimental Medical Sciences, 7(5), 143-151. https://doi.org/10.11648/j.ijcems.20210705.13

Copy | Download

ACS Style

Alberto Dariel Ramirez Gonzalez; Mabel Montero Castrillon; Lazaro Vazquez Vazquez. Characterization of COVID-19 Patients in an Intensive Care Unit. Int. J. Clin. Exp. Med. Sci. 2021, 7(5), 143-151. doi: 10.11648/j.ijcems.20210705.13

Copy | Download

AMA Style

Alberto Dariel Ramirez Gonzalez, Mabel Montero Castrillon, Lazaro Vazquez Vazquez. Characterization of COVID-19 Patients in an Intensive Care Unit. Int J Clin Exp Med Sci. 2021;7(5):143-151. doi: 10.11648/j.ijcems.20210705.13

Copy | Download

@article{10.11648/j.ijcems.20210705.13,
  author = {Alberto Dariel Ramirez Gonzalez and Mabel Montero Castrillon and Lazaro Vazquez Vazquez},
  title = {Characterization of COVID-19 Patients in an Intensive Care Unit},
  journal = {International Journal of Clinical and Experimental Medical Sciences},
  volume = {7},
  number = {5},
  pages = {143-151},
  doi = {10.11648/j.ijcems.20210705.13},
  url = {https://doi.org/10.11648/j.ijcems.20210705.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20210705.13},
  abstract = {At the end of 2019 a new coronavirus caused an epidemic of acute respiratory disease in Wuhan, China. The World Health Organization called this condition "coronavirus disease 2019" and declared it pandemic on 11 March 2020. On that same date the first three COVID-19 cases were diagnosed in Cuba. The Acute Physiology and Chronic Health Evaluation II (APACHE II) is the disease severity scoring system most commonly used in ICUs. An observational descriptive prospective cohort study was carried out with the objective of describing the behavior of 20 SARS-CoV-2 positive cases in an intensive care unit. This was realized from March to July 2020 at the Intensive Care Unit of Dr Salvador Allende Clinical Surgical Hospital in Havana, Cuba. The study population was all the patients admitted for positive SARS-CoV-2 (n=20). Mean age was 64.35±15.21 years. Male sex prevailed. Mean hospital stay was 10.05±5.5 days. Mean APACHE II was 16.6±8.9. The prevailing symptoms were fever (55%), coughing (25%) and dyspnea (20%). Mortality of COVID-19 patients was associated to age, a longer stay in the intensive care unit, high APACHE II scores, reduced erythrosedimentation values and lymphocyte count. Hypertension was the most common pathological antecedent.},
 year = {2021}
}

Copy | Download